Orion Nutraceuticals, Inc. (TSE:ORI)
CNQX:ORI
Canadian Market

Orion Nutraceuticals (ORI) Income Statement

1 Followers

Orion Nutraceuticals Income Statement

Last quarter (Q2 2024), Orion Nutraceuticals's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, Orion Nutraceuticals's net income was C$431.34K. See Orion Nutraceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
May 23May 22May 21May 20May 19
Total Revenue
----C$ 0.00C$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 259.83KC$ 279.69KC$ 282.39KC$ 552.50KC$ 543.10KC$ 3.03M
Operating Income
C$ -259.83KC$ -279.69KC$ -282.39KC$ -552.50KC$ -543.10KC$ -3.03M
Net Non Operating Interest Income Expense
------
Other Income Expense
C$ -297.80K-C$ -58.00KC$ -330.44KC$ 156.85KC$ -3.36M
Pretax Income
C$ 37.97KC$ -279.69KC$ -2.62MC$ -882.94KC$ -386.24KC$ -6.39M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ 37.97KC$ -279.69KC$ -2.62MC$ -882.94KC$ -385.32KC$ -6.39M
Basic EPS
C$ 0.01C$ -0.01C$ -0.09C$ -0.03C$ -0.20C$ -3.75
Diluted EPS
C$ 0.01C$ -0.01C$ -0.09C$ -0.03C$ -0.20C$ -3.75
Basic Average Shares
C$ 117.23MC$ 29.31MC$ 29.31MC$ 26.64MC$ 1.91MC$ 1.74M
Diluted Average Shares
C$ 117.23MC$ 29.31MC$ 29.31MC$ 26.64MC$ 1.91MC$ 1.74M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 0.00C$ 381.97K
Total Expenses
C$ 259.83KC$ 279.69KC$ 282.39KC$ -552.50KC$ 543.10KC$ 3.03M
Net Income From Continuing And Discontinued Operation
C$ 37.97KC$ -279.69KC$ -2.62MC$ -882.94KC$ -385.32KC$ -6.39M
Normalized Income
C$ 230.11KC$ -205.57KC$ 679.52KC$ -648.96KC$ -542.17KC$ -3.03M
Interest Expense
------
EBIT
C$ 37.97KC$ -279.69KC$ -2.62MC$ -882.94KC$ -543.10KC$ -3.03M
EBITDA
C$ 37.97KC$ -279.69KC$ -2.62MC$ -882.94KC$ -543.10KC$ -3.03M
Currency in CAD

Orion Nutraceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis